Surgical therapy of early non-small cell lung cancer

Chest

Volumn 117, Issue 4 SUPPL. 1, 2000, Pages 104S-109S

  Deslauriers, Jean ^a   Grégoire, Jocelyn ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Early stage non small cell lung cancer; Stage I non small cell lung cancer; Surgery

Indexed keywords

CANCER LOCALIZATION; CANCER RISK; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0343238262     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.4_suppl_1.104S     Document Type: Conference Paper

References (54)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
2. Nesbitt JC, Putnam JB, Walsh GL, et al. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995; 60:466-472
3. Bollen ECM, van Duin CJ, Theunissen PHMH, et al. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg 1993; 55:961-966
4. Izbicki JR, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995; 59:209-214
5. American Joint Committee on Cancer Lung. In: Beahrs OH, Hensen DE, Hutter RVP, et al, eds. Manual for staging cancer. 4th ed. Philadelphia, PA: Lippincott, 1992; 115-121
6. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983; 127:1-6
7. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723
8. Thomas P, Rubinstein L, for the Lung Cancer Study Group. Cancer recurrence after resection: T1N0 non-small cell lung cancer. Ann Thorac Surg 1990; 49:242-247
9. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(suppl):225S-233S
10. Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981; 82:70-76
11. Thomas PA, Rubinstein L, for the Lung Cancer Study Group. Malignant disease appearing late after operation for T1N0 non-small cell lung cancer. J Thorac Cardiovasc Surg 1993; 106:1053-1058
12. Tockman MS, Gupta PK, Myars JD, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988; 6:1685-1693
13. Pairolero PC, Williams DE, Bergstralh EJ, et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984; 38:331-338
14. Martini N, Bains MJ, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109:120-129
15. Ishida T, Yano T, Maeda K, et al. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 1990; 50:708-713
16. Padilla, Calvo V, Penalver JC, et al. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997; 63:324-326
17. Ichinose Y, Yano T, Asoh H, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: an analysis in each pathologic stage. J Thorac Cardiovasc 1995; 110:601-605
18. Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993; 106:90-94
19. Thomas PA, Piantadosi S, for the Lung Cancer Study Group. Postoperative T1N0 non-small-cell lung cancer: squamous versus non-squamous recurrences. J Thorac Cardiovasc Surg 1987; 94:349-354
20. Feld R, Rubinstein LV, Weisenberger TH, et al. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984; 2:1352-1357
21. Mountain CF, Lukeman JM, Hammar SP. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987; 35:147-156
22. Gail MH, Eagan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small-cell lung cancer: a report from the Lung Cancer Study Group. Cancer 1984; 64:1802-1813
23. Jackman RF, Good CA, Clagett OT, et al. Survival rates in peripheral bronchogenic carcinomas up to four centimeters in diameter presenting as solitary pulmonary nodules. J Thorac Cardiovasc Surg 1969; 57:1-8
24. Read RD, Yoder G, Schaeffer RC. Survival after conservative resection for T1N0M0 non-small-cell lung cancer. Ann Thorac Surg 1990; 49:391-400
25. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-447
26. Watanabe Y, Shimizu J, Oda M, et al. Early hilar lung cancer: its clinical aspect. J Surg Oncol 1991; 48:75-80
27. Deslauriers J, Brisson J, Cartier R, et al. Carcinoma of the lung: evaluation of satellite nodules as a factor influencing prognosis after resection. J Thorac Cardiovasc Surg 1989; 97:504-512
28. Kessler R, Gasser B, Massard G, et al. Blood vessel invasion is a major prognostic factor in resected non-small-cell lung cancer. Ann Thorac Surg 1996; 62:1489-1493
29. Macchiarini P, Fontanini G, Hardin JM, et al. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion: rationale for treatment with wedge resection alone. J Thorac Cardiovasc Surg 1992; 104:892-899
30. Jensik RJ, Faber LP, Milloy FG, et al. Segmental resection for lung cancer: a fifty-year experience. J Thorac Cardiovasc 1973; 66:563-572
31. Bennett WF, Abbey Smith R. Segmental resection for bronchogenic carcinoma: a surgical alternative for the compromised patient. Ann Thorac Surg 1979; 27:169-172
32. Hoffmann TH, Ramsdell HT. Comparison of lobectomy and wedge resection for carcinoma of the lung. J Thorac Cardiovasc Surg 1980; 79:211-217
33. Kutschera W. Segment resection for lung cancer. Thorac Cardiovasc Surg 1984; 32:102-104
34. Errett LE, Wilson J, Chiu RCJ, et al. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg 1985; 90:656-661
35. Miller JI, Hatcher CR. Limited resection of bronchogenic carcinoma in the patient with impairment of pulmonary function. Ann Thorac Surg 1987; 44:340-343
36. Pastorino U, Valente M, Bedini V, et al. Limited resection for stage I lung cancer. Eur J Surg Oncol 1991; 17:42-46
37. Kodama K, Doi O, Higashiyama M, et al. Intentional limited resection for selected patients with T1N0M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 1997; 114:347-353
38. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994; 107:1087-1094
39. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1N0M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:691-700
40. Ginsberg RJ, Rubinstein LU, for the Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0M0 non-small-cell lung cancer. Ann Thorac Surg 1995; 60:615-623
41. Lewis RJ. The role of video-assisted thoracic surgery for carcinoma of the lung: wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 1993; 56:762-768
42. Miller JI. Limited resection of bronchogenic carcinoma in the patient with impaired pulmonary function. Ann Thorac Surg 1993; 56:769-771
43. Martini N, Flehinger BJ, Nagasaki F, et al. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1983; 86:646-653
44. Martini N, Burt ME, Bains MS, et al. Survival after resection of stage II non-small-cell lung cancer. Ann Thorac Surg 1992; 54:460-466
45. Holmes EC. Treatment of stage II lung cancer. Surg Clin North Am 1987; 67:945-949
46. The Ludwig Lung Cancer Group. Patterns of failure in patients with resected stage I and II non-small cell carcinoma of the lung. Ann Surg 1987; 205:67-71
47. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-447
48. Yano T, Yokohama H, Inove T, et al. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 1994; 107:1398-1402
49. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986; 313:1377-1381
50. Feld R, Rubinstein L, Thomas PA, et al. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. J Natl Cancer Inst 1993; 85:299-306
51. Figlin RA, Piantadosi S. A phase 3 randomized trial of immediate combination chemotherapy vs delayed chemotherapy in patients with completely resected stage II and III non-small-cell carcinoma of the lung. Chest 1994; 106(suppl): 310S-312S
52. Non-Small-Cell Lung Cancer Collaborative Group. Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311:899-909
53. Logan DM, Lochrin CA, Darling G, et al. Adjuvant radiotherapy and chemotherapy for stage II and III-A non-small-cell lung cancer after complete resection. Cancer Prev Control 1997; 1:366-378
54. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11:1216-1222